van den Belt-Dusebout AW - Search Results

1

Risk of diabetes after para-aortic radiation for testicular cancer.

Groot HJ, Gietema JA, Aleman BMP, Incrocci L, de Wit R, Witjes JA, Groenewegen G, de Brouwer P, Meijer OWM, Hulshof MCCM, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, van den Bergh ACM, Kerst JM, van den Belt-Dusebout AW, Lubberts S, Jóźwiak K, Horenblas S, van Leeuwen FE, Schaapveld M. Groot HJ, et al. Among authors: van den belt dusebout aw. Br J Cancer. 2018 Oct;119(7):901-907. doi: 10.1038/s41416-018-0248-x. Epub 2018 Oct 9. Br J Cancer. 2018. PMID: 30297773 Free PMC article.

2

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD Jr, Burgers JM, Somers R. van Leeuwen FE, et al. J Natl Cancer Inst. 1995 Oct 18;87(20):1530-7. doi: 10.1093/jnci/87.20.1530. J Natl Cancer Inst. 1995. PMID: 7563187

3

Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R. van Leeuwen FE, et al. J Clin Oncol. 1994 Feb;12(2):312-25. doi: 10.1200/JCO.1994.12.2.312. J Clin Oncol. 1994. PMID: 8113838

4

Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.

van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW, Hagenbeek A, Noyon R, van Kerkhoff EH, Pinedo HM, Somers R. van Leeuwen FE, et al. J Clin Oncol. 1994 May;12(5):1063-73. doi: 10.1200/JCO.1994.12.5.1063. J Clin Oncol. 1994. PMID: 8164031

5

Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.

van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, Noyon R, Eliel MR, van Kerkhoff EH, Delemarre JF, Somers R. van Leeuwen FE, et al. J Clin Oncol. 1993 Mar;11(3):415-24. doi: 10.1200/JCO.1993.11.3.415. J Clin Oncol. 1993. PMID: 8445415

6

Long-term cause-specific mortality of patients treated for Hodgkin's disease.

Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van't Veer MB, Bartelink H, van Leeuwen FE. Aleman BM, et al. J Clin Oncol. 2003 Sep 15;21(18):3431-9. doi: 10.1200/JCO.2003.07.131. Epub 2003 Jul 28. J Clin Oncol. 2003. PMID: 12885835

7

Long-term survivors of acute lymphoblastic leukemia.

Nuver J, van den Belt-Dusebout AW, Gietema JA. Nuver J, et al. N Engl J Med. 2003 Nov 13;349(20):1973; author reply 1973. doi: 10.1056/NEJM200311133492019. N Engl J Med. 2003. PMID: 14614176 No abstract available.

8

Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.

van den Belt-Dusebout AW, Nuver J, de Wit R, Gietema JA, ten Bokkel Huinink WW, Rodrigus PT, Schimmel EC, Aleman BM, van Leeuwen FE. van den Belt-Dusebout AW, et al. J Clin Oncol. 2006 Jan 20;24(3):467-75. doi: 10.1200/JCO.2005.02.7193. J Clin Oncol. 2006. PMID: 16421423

9

Late cardiotoxicity after treatment for Hodgkin lymphoma.

Aleman BM, van den Belt-Dusebout AW, De Bruin ML, van 't Veer MB, Baaijens MH, de Boer JP, Hart AA, Klokman WJ, Kuenen MA, Ouwens GM, Bartelink H, van Leeuwen FE. Aleman BM, et al. Blood. 2007 Mar 1;109(5):1878-86. doi: 10.1182/blood-2006-07-034405. Epub 2006 Nov 21. Blood. 2007. PMID: 17119114 Free article.

10

Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.

van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG, Hoekstra HJ, Ouwens GM, Aleman BM, van Leeuwen FE. van den Belt-Dusebout AW, et al. J Clin Oncol. 2007 Oct 1;25(28):4370-8. doi: 10.1200/JCO.2006.10.5296. J Clin Oncol. 2007. PMID: 17906202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page